INTRODUCTION
============

Modern horses (*Equus caballus*) have evolved for over 50 million years from the genus *Eohippus.* Since 4000 B.C., horses have been selected by humans on the basis of strength, speed, and endurance ([@b15-molce-40-10-796]). A large number of horse subspecies have been domesticated and bred in regard to improvement of improve speed, endurance, and agility. Only one wild subspecies (Przewalski's horse) has survived to the present day ([@b25-molce-40-10-796]; [@b35-molce-40-10-796]). Thoroughbred horses have been specifically bred for racing ability; therefore, many studies have examined genetic traits related to athletic performance ([@b6-molce-40-10-796]; [@b17-molce-40-10-796]; [@b36-molce-40-10-796]). The Jeju breed of horses has been developed over centuries by interbreeding the native horses of Jeju, Korea with the 160 Mongolian horses introduced by the invading Mongolian army in 1276. These horses have been bred for farming, as a food source, and for racing in the Jeju province in South Korea. Jeju horses are small; however, they are robust and possess a high level of endurance. Many studies have focused on elucidating the phylogenetic relationships as well as genetic characteristics of Jeju horses ([@b8-molce-40-10-796]; [@b41-molce-40-10-796]). Research on Thoroughbred horses has focused on improving racing ability. Therefore, genetic research on the Jeju horse may help predicting of phylogenetic relationships and identifying traits specific to the Jeju horse. New approaches are required for the investigation of racing ability, subspecies-specific traits, evolutionary traits, as well as the phylogenetic diversity of horse subspecies.

Retroviral infections resulting in germline integration have an important role in vertebrate evolutionary diversification. Endogenous retrovirus (ERV) sequences account for about 5--10% of host genome and have been identified in all mammals and most vertebrates. Following integration into the host genome, retroviruses are transmitted from ancestors to progeny according to Mendelian inheritance principles and eventually form repeat elements (long terminal repeat (LTR) elements) ([@b5-molce-40-10-796]; [@b19-molce-40-10-796]). The full-length ERV genome comprises *gag* (group-specific antigen), *prt* (protease), *pol* (polymerase), and *env* (envelope) genes as well as LTR elements at both ends. Primer binding sites (PBS) also exist between the 5′-LTR and the *gag* gene. Most ERVs display a truncated LTR, although some ERVs display a full-length sequence. These ERV sequences induce genomic instability via mutational events, such as retrotranspositions and genomic rearrangements ([@b10-molce-40-10-796]; [@b18-molce-40-10-796]). When two LTR elements are integrated into the host genome, they initially display identical sequences that subsequently diverge at a rate of 0.13--0.21% over a period of a million years. Therefore, it is possible to estimate the point in time of integration by assessing the divergence between two LTR sequences ([@b43-molce-40-10-796]). ERVs are classified according to their PBS that are highly homologous to host tRNA complement sequences ([@b43-molce-40-10-796]).

Human endogenous retroviruses (HERVs) have many well-known functions, e.g., they are potential pathogens, alternative LTR promoters, and are involved in syncytin production in humans ([@b9-molce-40-10-796]; [@b29-molce-40-10-796]; [@b40-molce-40-10-796]). Horses also have ERVs, referred to as equine ERVs (EqERVs) ([@b7-molce-40-10-796]; [@b12-molce-40-10-796]; [@b19-molce-40-10-796]; [@b44-molce-40-10-796]). In the equine genome, full-length beta-EqERV genomes have been identified ([@b44-molce-40-10-796]). Fifteen EqERV types belonging to three classes were detected by *in silico* methods ([@b12-molce-40-10-796]). ERVs have the potential to alter the phenotype of different species, and EqERVs may also provide evolutionary information related to the traits of horses ([@b13-molce-40-10-796]; [@b19-molce-40-10-796]). According to transcriptome analyses, EqERV-mRNAs are expressed in various horse tissues ([@b7-molce-40-10-796]). The expression of ERVs has previously been identified by the detection of ERV-derived transcripts ([@b3-molce-40-10-796]; [@b37-molce-40-10-796]). Some ERV coding regions (*gag*, *pol*, and *env*) have complete open reading frames (ORFs); interrupted ERV ORFs have also been detected. ERV genes are transcribed at high levels, and corresponding proteins are expressed more frequently in cancer than in normal tissues ([@b3-molce-40-10-796]; [@b22-molce-40-10-796]; [@b40-molce-40-10-796]). Some ERV families tend to exhibit ubiquitous expression in various organs, while others show tissue-specific expression patterns ([@b3-molce-40-10-796]; [@b2-molce-40-10-796]). We identified EqERVs in the horse genome and characterized their genomic organization. To date, no studies have been undertaken to evaluate the expression patterns of EqERVs in horse samples. Thus, the EqERV expression patterns were examined in the cerebrum and cerebellum of a Thoroughbred as well as a Jeju horse.

MATERIALS AND METHODS
=====================

Ethics statement
----------------

All animal trials approved by the Pusan National University-Institutional Animal Care and Use Committee (PNU-IACUC) (Approval Number for horse tissue samples: PNU-2013-0411). All biopsies were taken under the guidance of a veterinarian. Efforts were made to minimize animal stress and pain.

Horse samples
-------------

Cerebrum and Cerebellum tissue of individual Thoroughbred and Jeju horses obtained from the Subtropical Animal Experiment Station of the Rural Development Administration, South Korea. Total RNA was extracted using a standard TRIzol®-based purification protocol (Invitrogen, USA) and quantified using NanoDrop technology (Thermo Fisher Scientific Inc., USA). Then, RNA was adjusted to concentrations of 500 ng per samples. M-MLV (Moloney-Murine Leukemia Virus) reverse transcriptase (Promega, USA) was used for cDNA synthesis according to instructions of the manufacturer (Promega).

Identification of EqERV families
--------------------------------

The *Equus caballus* (equCab2) genome assembly of a Thoroughbred horse was retrieved from NCBI Assembly (<http://www.ncbi.nlm.nih.gov/assembly/286598/>). In UCSC Genome Browser, BLAT was used to search for ERVs in the horse genome, and well-known full-length retrovirus DNA sequences were used as search queries. The resulting sequences were expanded to include upstream and downstream regions for total lengths of 1.5×, then retrieved ERV-sequences were queried using RetroTector (<http://retrotector.neuro.uu.se/>). EqERV was used to refer to the ERVs described in this work based on the previously described nomenclature ([@b12-molce-40-10-796]).

Bioinformatic analysis
----------------------

EqERVs were classified according to the PBS and identified by length. Each LTR sequence was aligned using ClustalW in MEGA7 (<http://www.megasoftware.net/>). The point in time of integration of EqERVs was assessed based on the divergence of each LTR ([@b21-molce-40-10-796]). The tRNA sequences were downloaded from the genomic tRNA database (<http://gtrnadb.ucsc.edu>) and the PBS sites were aligned with tRNA sequences in BioEdit ([@b16-molce-40-10-796]). The PBS sites not matching with tRNA sequences were realigned using the RetroTector PBS site ([@b42-molce-40-10-796]). Sequence divergences between two LTR sequences were assessed by the Kimura two-parameter method in MEGA7 ([@b23-molce-40-10-796]). Neighbor-joining trees were constructed using MEGA7, with 100 bootstrap replicates ([@b23-molce-40-10-796]). The percentage of bootstrap replicates supporting the branch is revealed at each node. The ORFs of *gag*, *pol*, *env* region were retrieved by a BLASTx search ([@b20-molce-40-10-796]).

RT-qPCR amplification
---------------------

EqERV *pol* transcripts were detected by reverse transcription quantitative real-time PCR (RT-qPCR) using the primers shown in [Table 1](#t1-molce-40-10-796){ref-type="table"}. We designed primer sets using the Primer3 program (<http://bioinfo.ut.ee/primer3-0.4.0/>). The RT regions of the EqERV *pol* gene were amplified. Each reaction only yielded one amplification product as determined by melting curve analyses. No-template controls were consistently tested negative. For normalization, the beta-2-microglobulin (*B2M*) gene was amplified as previously described ([@b1-molce-40-10-796]). RT-qPCR amplification was performed as follows: 30 cycles of 95°C for 30 s, 55°C for 30 s, 72°C for 30 s, and a final elongation at 72°C for 7 min using a Mastercycler® Pro S Thermocycler (Effendorf, Hamburg, Germany). The conditions for the RT-qPCR amplification of EqERV elements and the *B2M* gene were 45 cycles of 95°C for 10 s, 58°C for 15 s, and 72°C for 15 s. A melting curve analysis was performed for 30 s at 55°C to 99°C using a Rotor-Gene Q (Qiagen, Hilden, Germany). All samples were amplified in triplicate to guarantee reproducibility.

RESULTS AND DISCUSSION
======================

Identification and point of divergence of EqERVs in the horse genome
--------------------------------------------------------------------

We analyzed EqERVs in the horse genome by an *in silico* method using the RetroTector. We confirmed the locations in the genome, retroviral genes, PBS regions, and LTR pairs of each EqERV family. In the horse whole genome, a total of 22 EqERV types were detected by PBS analysis (EqERV-E, I, M, P, S, and Y) ([Fig. 1](#f1-molce-40-10-796){ref-type="fig"} and [Table 2](#t2-molce-40-10-796){ref-type="table"}). Based on a comparative analysis of the reverse complement of PBS and tRNA sequences, we determined the first amino acid combined with the tRNA, and assigned the following EqERV family names: EqERV-E1, EqERV-I1, EqERV-M2, EqERV-P1, EqERV-S1, and EqERV-Y4 ([Fig. 2](#f2-molce-40-10-796){ref-type="fig"}). In all EqERV families, the surface (SU) component of the *env* gene was interrupted. The matrix (MA) domain of the *gag* gene was only detected, and full-length ORFs of viral genes (*gag* and *env*) were identified in EqERV-E1. The *prt* gene was truncated in EqERV-P1, EqERV-S1, and EqERV-Y4. EqERV-P1 and EqERV-S1 showed a long capsid (CA) domain compared to viruses of other families, however full-length ORFs of the *gag* gene were not detected. Additionally, long integrase (IN) and transmembrane (TM) domains were detected in EqERV-P1, while a long reverse transcriptase (RT) domain in the *pol* region was observed for EqERV-I1. The EqERV-S1 has full-length ORFs of three viral genes (*gag*, *pol*, and *env*), but other EqERVs has at least one interrupted ORFs in these sequences ([Fig. 1](#f1-molce-40-10-796){ref-type="fig"}). In the host, the activation of restriction factors was not need to full-length ORFs, and interrupted ORFs could regulate immune systems or other biological roles ([@b30-molce-40-10-796]). Thus, all these EqERV domains appear to have important biological roles in horses.

Both LTRs located in the 5′ and 3′ flanking regions are important for retroviral replication. We analyzed the LTR sequences to estimate the point in time of integration based on divergence values, because both LTR sequences can help to estimate their insertion time. The same LTR sequences were attached to each 5′- and 3′-end during retroviral replication, and differences in these LTR sequences arise during evolution. Therefore, it could be possible to estimate the moment of integration time of ERVs based on the divergence values ([@b21-molce-40-10-796]). Garcia-Etxebarria and Jugo estimated the point in time of integration at 45--21 million years ago (Mya) and 6-3 Mya ([@b12-molce-40-10-796]). Thus, these two types are the youngest members of class I. Our estimated LTR divergence values indicated that EqERV-Y1 and Y3 proliferated approximately 35.9 Mya and 2.8 Mya based on average evolutionary rate of 0.2% per million years (Myr) ([Table 2](#t2-molce-40-10-796){ref-type="table"}). This evolutionary rate was also applied to ERV-H divergence in primates ([@b4-molce-40-10-796]). Depend on the species, different evolutionary rates (0.12%/Myr, 0.2%/Myr, and 0.26%/Myr) could be used for ERV studies in humans and apes ([@b26-molce-40-10-796]). In our previous studies, the average evolutionary rate of 0.2%/Myr was used for humans and primates ([@b45-molce-40-10-796]; [@b47-molce-40-10-796]). After that, integration time based on ERV was estimated in novel methods ([@b31-molce-40-10-796]), and various species in mammals ([@b27-molce-40-10-796]). In mammalian genome, insertion time is estimated by the divergence between 5′LTR and 3′LTR ([@b27-molce-40-10-796]). As shown in [Table 2](#t2-molce-40-10-796){ref-type="table"}, we estimated the divergence time of EqERV families assuming an evolutionary rate of 0.2%/Myr. Divergence time was estimated as 49.1 Mya in EqERV-Y2 and 5.6 Mya in EqERV-Y4. As an old EqERV family, EqERV-S3 (75.4 Mya) was detected on chromosome 10, and EqERV-P5 (1.2 Mya) was identified as a young member on chromosome 12. During the evolutionary diversification of horses, the diversification of the EqERV-I family took 1.7 Mya to 38.7 Mya ([Table 2](#t2-molce-40-10-796){ref-type="table"}). The evolution of the horse species occurred over a period of 55 million years ([@b28-molce-40-10-796]). According to our data and a previous report ([@b12-molce-40-10-796]), some EqERVs integrated into the horse genome during the evolution of the horse lineage. The *Equus* genus consists of three clades. One clade is the domesticated horse, including Thoroughbred, Arab, Jeju, and Mongolian horse (*E. caballus*) breeds. The other two clades comprise zebras and donkeys. These clades split 3 million years ago ([@b28-molce-40-10-796]; [@b34-molce-40-10-796]). Most EqERV integrations occurred earlier, as indicated by herein presented and other published data ([@b12-molce-40-10-796]). The HERV-S family has been detected in hominoids, Old World monkeys, and New World monkeys. However, it does not exist in prosimians, indicating that HERV-S integrated into the primate genome approximately 43 million years ago ([@b46-molce-40-10-796]). Taken together, EqERV families integrated at different points in time, and therefore variant evolutionary patterns are observed in the equine genome.

Phylogenetic analysis of identified EqERVs
------------------------------------------

We compared the relationship of the identified EqERV families with the EqERVs derived from previous studies using phylogenetic analysis ([Fig. 3](#f3-molce-40-10-796){ref-type="fig"}). Firstly, EqERV-beta1 was firstly identified in chromosome 5 ([@b44-molce-40-10-796]). Then, Brown et al. identified the EqERV *pol* genes of beta-, gamma-, and epsilon-retroviruses ([@b7-molce-40-10-796]), as well as Garcia-Etxebarria and Jugo identified the three classes of EqERVs in horse genome ([@b12-molce-40-10-796]). The phylogenetic tree was generated by the neighbor-joining method, with the EqERV RT regions, because the same families of ERV have similar RT regions ([@b43-molce-40-10-796]). EqERV-S3 was excluded from the phylogenetic analysis because of its short RT region. HERV-Y is recently identified ([@b14-molce-40-10-796]), and EqERV-Y is also identified in the horse genome ([@b12-molce-40-10-796]). In the previous study, EqERV7, EqERV8 were class I, EqERV12 was class II, and EqERV10 was class III, respectively ([@b12-molce-40-10-796]). Class I EqERVs were included with epsilon-retrovirus, and our EqERV-Y families were included with gamma-retrovirus. Beta-retrovirus, EqERV-beta1, and class II EqERV12 were included in same group, and class III EqERV10 was out-grouped ([Fig. 3](#f3-molce-40-10-796){ref-type="fig"}). In the previous studies, the phylogenetic relationships of EqERVs were compared with other ERVs ([@b7-molce-40-10-796]; [@b12-molce-40-10-796]; [@b44-molce-40-10-796]). In this study, we revealed the phylogenetic relationship of six EqERV families, which can provide insights into the family-specific functions.

Expression analysis of EqERV *pol* in horse tissues of two subspecies
---------------------------------------------------------------------

Many researchers have proposed ERV-derived transcripts or proteins as potential pathological factors. ERV *gag*, *pol*, and *env* gene transcripts and proteins are expressed in various cancer tissues at higher levels than in normal tissues ([@b3-molce-40-10-796]; [@b39-molce-40-10-796]). The expression of ERV genes has many effects in host organisms. In a previous study, 978 EqERV-derived *gag*, *pol*, and *env* transcripts were detected in horse tissues based on a whole transcriptome analysis ([@b7-molce-40-10-796]). According to a phylogenetic analysis of EqERV transcripts, EqERVs are closely related to bovine ERVs. Therefore, it is necessary to elucidate their biological functions and expression patterns. In general, viral genes have potentially detrimental effects, and integrated viral genes in the host genome may also have deleterious effects on the host. The functions of HERV transcripts, HERV proteins, and even HERV-derived particles are extensively in various human tissues, most notably in cancer tissues. The best example of an ERV function is that of HERV-W *env*, which has an important role in placenta formation. In order to characterize ERV transcripts, it is important to identify tissue-specific expression patterns. Likewise, HERV-W *env* also presents expression patterns specific for brain diseases or brain cells, which suggests that the expression of ERVs can have immunopathogenic and neuroinflammatory roles in the host ([@b11-molce-40-10-796]; [@b38-molce-40-10-796]). Accordingly, the elucidation of ERV expression patterns in the brain is important to determine the exact role of the virus in this area. Therefore, we assessed the expression of EqERV in two brain specimens obtained from a Thoroughbred horse and a Jeju horse. Primers were designed to amplify the *pol* RT regions in the whole transcriptome using the Tablet graphical viewer ([@b32-molce-40-10-796]). As shown in [Fig. 4](#f4-molce-40-10-796){ref-type="fig"}, we examined the expression patterns of *pol* by RT-qPCR. EqERV-E1 *pol* was expressed at higher levels in the Jeju horse than in the Thoroughbred, particularly in the cerebellum ([Fig. 4A](#f4-molce-40-10-796){ref-type="fig"}). Each *pol* gene of EqERV-I1, M2, P1, S1, and Y4 showed higher expression in the cerebellum of the Jeju horse than the Thoroughbred ([Fig. 4](#f4-molce-40-10-796){ref-type="fig"}). In humans, HERV-P *pol* expression was detected in brain and testis tissues ([@b47-molce-40-10-796]), while HERV-S *pol* is specifically expressed patterns in the brain and thymus ([@b46-molce-40-10-796]). The viral ERV genes can induce the proinflammatory cytokines in brain and immune system, and have crucial roles in the development and regulates central nervous system (CNS) ([@b24-molce-40-10-796]; [@b33-molce-40-10-796]). Then, pharmacological-induction of ERV genes could regulate the function of the brain or CNS. These expression data may provide the clues of Thoroughbred and Jeju horse specific pharmacological-induction of ERVs, and improve the breeding system of each horses. Thus, various expression patterns of EqERV *pol* in brain tissues could be of great use for further functional studies in horse research.
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![Structural analysis of full-length EqERVs located at specific loci on horse chromosomes\
The depicted structures were analyzed using EqERV sequences from the horse genome equCab2 assembly with the RetroTector10 program. The interrupted regions and full-length ORFs were indicated as dot lines and solid lines with bold type, respectively. These EqERVs harbor a 5′ LTR-*gag*-(*prt*)-*pol*-*env*-3′ LTR structure.](molce-40-10-796f1){#f1-molce-40-10-796}

![Alignment of LTR sequences and PBS with tRNA sequences of six novel EqERV families\
EqERV LTR lengths differ depending on the family.](molce-40-10-796f2){#f2-molce-40-10-796}

![Phylogenetic trees based on the *pol* RT regions of identified EqERVs\
The tree was generated by the neighbor-joining method. Bootstrap evaluation of the branching patterns was executed with 100 replicates. Branch lengths are matched to genetic distance. EqERVs identified in previous studies were indicated as asterisks. \*([@b7-molce-40-10-796]), \*\*([@b12-molce-40-10-796]), \*\*\*([@b44-molce-40-10-796]).](molce-40-10-796f3){#f3-molce-40-10-796}

![Quantitative expression of six novel EqERV families in Thoroughbred and Jeju horse tissues by RT-qPCR\
Relative expression levels of EqERV genes were normalized to the expression levels of horse *B2M* genes. TH1 indicates the Thoroughbred horse cerebrum and TH2 indicates the cerebellum. JH1 indicates the Jeju horse cerebrum and JH2 indicates the cerebellum. Compared between Thoroughbred and Jeju horse in each tissues, significantly different expression patterns were indicated as asterisks (\**p* \< 0.05, \*\**p* \< 0.005).](molce-40-10-796f4){#f4-molce-40-10-796}

###### 

List of RT-qPCR primers used for the amplification of the EqERV *pol* gene in Thoroughbred and Jeju horses

  EqERV family                Direction   Primer sequences        Product size (bp)   Location in genome
  --------------------------- ----------- ----------------------- ------------------- ------------------------------
  EqERV-E1 *pol*              Forward     GGTACAGAGAGGGAGGCACA    132                 chr1:183,840,430-183,840,561
                              Reverse     TTGAGGCTGATTGCTTTTGA                        
  EqERV-I1 *pol*              Forward     ACCCCATCTGCACTGAAATC    140                 chrX:74,309,270-74,309,383
                              Reverse     CCCGAGTTGAGGGTTAGGG                         
  EqERV-P1 *pol*              Forward     TGTGGGTCCTTCTAGTTGTGG   134                 chr7:49,472,758-49,472,891
                              Reverse     CGAGGGGTTAAGTTCACACG                        
  EqERV-M2 *pol*              Forward     TGGAAAAAGGCAAAGACAAA    125                 chr5:16,128,363-16,128,487
                              Reverse     CTGAAGTGGCCACCAACTTT                        
  EqERV-S1 *pol*              Forward     CATGGCACTGCTCATCAAAC    114                 chrX:95,866,328-95,866,441
                              Reverse     TTCCTTTTTCTCCCCAAAGC                        
  EqERV-Y4 *pol*              Forward     GGGAGGTCAGAGCCTTGTTT    142                 chr1:29,481,664-29,481,805
                              Reverse     ACGTCCTTTTCTTGGCATCC                        
  *B2M* (for normalization)   Forward     CCTGCTCGGGCTACTCTC      89                  chr1:144,494,425-144,497,779
                              Reverse     CATTCTCTGCTGGGTGACG                         

###### 

Divergence times and evolutionary rates of EqERV families

                                                                                      Evolutionary time          
  ---------- ----- ------------------------------ ----- ----- -------- -------------- ------------------- ------ -------
  EqERV-E1   Glu   chr1:183,833,213-183,842,637   (+)   9.4   Full     16.6           27.7                41.6   55.5
  EqERV-I1   Ile   chrX:74,300,522-74,309,530     (+)   9.0   Full     2.9            4.8                 7.2    9.5
  EqERV-I2   Ile   chr11:46,777,889-46,786,573    (−)   8.7   Full     1.2            1.9                 2.9    3.9
  EqERV-I3   Ile   chr5:27,325,566-27,334,031     (−)   8.5   Full     0.7            1.1                 1.7    2.2
  EqERV-I4   Ile   chr7:47,466,052-47,474,526     (−)   8.5   Full     9.4            15.6                23.5   31.3
  EqERV-I5   Ile   chr11:55,535,777-55,544,146    (−)   8.3   Full     15.5           25.8                38.7   51.6
  EqERV-I6   Ile   chr1:111,609,131-111,617,366   (+)   8.2   Full     8.0            13.3                20.0   26.7
  EqERV-I7   Ile   chr4:105,090,068-105,096,011   (−)   5.9   Δ3′LTR   Not detected   \-                  \-     \-
  EqERV-M1   Met   chr7:43,693,479-43,702,540     (−)   9.1   Full     2.7            4.5                 6.8    9.1
  EqERV-M2   Met   chr5:16,127,484-16,135,151     (−)   7.7   Δ3′LTR   Not detected   \-                  \-     \-
  EqERV-P1   Pro   chr11:49,468,622-49,477,753    (+)   9.1   Full     1.7            2.9                 4.4    5.8
  EqERV-P2   Pro   chr2:11,712,296-11,721,196     (+)   8.9   Full     2.4            4.1                 6.1    8.1
  EqERV-P3   Pro   chr4:26,026,629-26,034,772     (+)   8.1   Δ3′LTR   Not detected   \-                  \-     \-
  EqERV-P4   Pro   chr10:26,653,364-26,660,774    (−)   7.4   Δ3′LTR   Not detected   \-                  \-     \-
  EqERV-P5   Pro   chr12:15,551,778-15,559,089    (−)   7.3   Full     0.5            0.8                 1.2    1.5
  EqERV-S1   Ser   chrX:44,328,238-44,336,882     (+)   8.6   Full     1.3            2.1                 3.1    4.2
  EqERV-S2   Ser   chr20:32,762,746-32,770,917    (−)   8.2   Full     30.2           50.3                75.4   100.5
  EqERV-S3   Ser   chr10:12,943,738-12,950,180    (+)   6.4   Δenv     10.6           17.7                26.6   35.4
  EqERV-Y1   Tyr   chrX:53,124,155-53,133,636     (+)   9.5   Full     14.4           23.9                35.9   47.9
  EqERV-Y2   Tyr   chrX:60,642,587-60,651,514     (+)   8.9   Full     19.6           32.7                49.1   65.5
  EqERV-Y3   Tyr   chr1:27,393,645-27,402,113     (+)   8.5   Full     1.1            1.9                 2.8    3.7
  EqERV-Y4   Tyr   chr1:29,478,335-29,485,604     (−)   7.2   Full     2.2            3.7                 5.6    7.4

PBS: Primer binding site,

Full: full-length, Δdeletion. Myr: million years

Divergence was estimated by the Kimura-2-parameter method. Evolutionary time was calculated following as T=d/2r (T: evolutionary time; d: divergence; r: evolutionary rate).
